Hippocratic AI is a startup that creates AI-powered medical devices. It highlights non-diagnostic duties like scheduling appointments and keeping track of patients. The business was estimated at $1.64 billion after increasing $141 million recently.
This finance will promote the company's product expansion and international market entry. Since its launch less than two years ago, it has operated with 23 insurers and health systems. Its objective is to improve patient care and assist medical professionals.
Hippocratic AI raises $141M for creating patient-facing AI agents
The business Hippocratic AI, which creates AI solutions for non-diagnostic patient-facing tasks, indicated Thursday that it had increased $141 million Series B at a $1.64 billion valuation managed by Kleiner Perkins. The funding comes five months after Hippocratic AI increased $17 million from Nvidia and nine months after the company increased $53 million from General Catalyst and Andreessen Horowitz. The company was launched less than two years ago.
Hippocratic AI addresses the lack of healthcare people by creating agents that can carry out basic activities, such as pre-operative procedures, remote patient examination, and appointment planning. In contrast, most healthcare-generative AI businesses focus on lowering administrative duties. As of 2024, the company had agreements with 23 companies and health systems. Hippocratic employs fresh funding to take the product into new markets and abroad.
Key Takeaways
- With a $141 million increase, Hippocratic AI was estimated at $1.64 billion.
- It builds AI agents for basic medical duties like remote monitoring and pre-operative procedures.
- The startup tackles the absence of healthcare professionals.
- It entered into contracts with 23 insurers and health systems in 2024.
- The new funding will help the company's international product expansion.